Swiss National Bank’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-209,486
| Closed | -$274K | – | 2559 |
|
|
2019
Q1 | $274K | Buy |
209,486
+45,200
| +28% | +$59.1K | ﹤0.01% | 2470 |
|
|
2018
Q4 | $150K | Sell |
164,286
-23,493
| -13% | -$21.5K | ﹤0.01% | 2530 |
|
|
2018
Q3 | $386K | Hold |
187,779
| – | – | ﹤0.01% | 2455 |
|
|
2018
Q2 | $338K | Hold |
187,779
| – | – | ﹤0.01% | 2497 |
|
|
2018
Q1 | $442K | Buy |
187,779
+22,517
| +14% | +$53K | ﹤0.01% | 2404 |
|
|
2017
Q4 | $311K | Buy |
165,262
+38,862
| +31% | +$73.1K | ﹤0.01% | 2487 |
|
|
2017
Q3 | $314K | Hold |
126,400
| – | – | ﹤0.01% | 2478 |
|
|
2017
Q2 | $348K | Hold |
126,400
| – | – | ﹤0.01% | 2498 |
|
|
2017
Q1 | $382K | Buy |
126,400
+19,888
| +19% | +$60.1K | ﹤0.01% | 2444 |
|
|
2016
Q4 | $336K | Hold |
106,512
| – | – | ﹤0.01% | 2498 |
|
|
2016
Q3 | $363K | Hold |
106,512
| – | – | ﹤0.01% | 2438 |
|
|
2016
Q2 | $243K | Buy |
106,512
+26,959
| +34% | +$61.5K | ﹤0.01% | 2542 |
|
|
2016
Q1 | $191K | Buy |
79,553
+14,629
| +23% | +$35.1K | ﹤0.01% | 2560 |
|
|
2015
Q4 | $215K | Hold |
64,924
| – | – | ﹤0.01% | 2565 |
|
|
2015
Q3 | $157K | Buy |
64,924
+10,407
| +19% | +$25.2K | ﹤0.01% | 2523 |
|
|
2015
Q2 | $160K | Buy |
+54,517
| New | +$160K | ﹤0.01% | 2559 |
|
|
2014
Q2 | – | Sell |
-35,188
| Closed | -$93K | – | 2540 |
|
|
2014
Q1 | $93K | Buy |
35,188
+12,266
| +54% | +$32.4K | ﹤0.01% | 2483 |
|
|
2013
Q4 | $67K | Hold |
22,922
| – | – | ﹤0.01% | 2500 |
|
|
2013
Q3 | $70K | Hold |
22,922
| – | – | ﹤0.01% | 2473 |
|
|
2013
Q2 | $73K | Buy |
+22,922
| New | +$73K | ﹤0.01% | 2489 |
|